PL188998B1 - Zastosowanie antagonistów LH-RH - Google Patents

Zastosowanie antagonistów LH-RH

Info

Publication number
PL188998B1
PL188998B1 PL97333174A PL33317497A PL188998B1 PL 188998 B1 PL188998 B1 PL 188998B1 PL 97333174 A PL97333174 A PL 97333174A PL 33317497 A PL33317497 A PL 33317497A PL 188998 B1 PL188998 B1 PL 188998B1
Authority
PL
Poland
Prior art keywords
hysteroscopy
cetrorelix
antagonists
antagonist
preparation
Prior art date
Application number
PL97333174A
Other languages
English (en)
Polish (pl)
Other versions
PL333174A1 (en
Inventor
Jürgen Engel
Klaus Diedrich
Ricardo Felberbaum
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of PL333174A1 publication Critical patent/PL333174A1/xx
Publication of PL188998B1 publication Critical patent/PL188998B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Endoscopes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Surgical Instruments (AREA)
PL97333174A 1996-10-30 1997-10-23 Zastosowanie antagonistów LH-RH PL188998B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19644994A DE19644994A1 (de) 1996-10-30 1996-10-30 Diagnostisches Mittel
PCT/DE1997/002456 WO1998018482A1 (de) 1996-10-30 1997-10-23 Verwendung von lh-rh antagonisten als diagnostisches mittel

Publications (2)

Publication Number Publication Date
PL333174A1 PL333174A1 (en) 1999-11-22
PL188998B1 true PL188998B1 (pl) 2005-05-31

Family

ID=7810344

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97333174A PL188998B1 (pl) 1996-10-30 1997-10-23 Zastosowanie antagonistów LH-RH

Country Status (21)

Country Link
US (1) US6106805A (pt)
EP (1) EP0938330B1 (pt)
JP (1) JP2001502702A (pt)
AR (1) AR008516A1 (pt)
AT (1) ATE212856T1 (pt)
AU (1) AU717538B2 (pt)
BR (1) BR9712456A (pt)
CA (1) CA2219641C (pt)
DE (2) DE19644994A1 (pt)
DK (1) DK0938330T3 (pt)
ES (1) ES2172818T3 (pt)
HU (1) HUP9904642A3 (pt)
IL (1) IL129293A (pt)
NO (1) NO323690B1 (pt)
NZ (1) NZ335065A (pt)
PL (1) PL188998B1 (pt)
PT (1) PT938330E (pt)
RU (1) RU2193414C2 (pt)
TW (1) TW534817B (pt)
WO (1) WO1998018482A1 (pt)
ZA (1) ZA979693B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5574011A (en) * 1995-04-04 1996-11-12 Tien; Henry C. Compositions and methods for the treatment of male-pattern baldness

Also Published As

Publication number Publication date
PT938330E (pt) 2002-07-31
AU717538B2 (en) 2000-03-30
DK0938330T3 (da) 2002-05-27
US6106805A (en) 2000-08-22
ES2172818T3 (es) 2002-10-01
NO991920D0 (no) 1999-04-22
HUP9904642A2 (hu) 2000-06-28
HUP9904642A3 (en) 2000-07-28
AR008516A1 (es) 2000-01-19
IL129293A (en) 2005-12-18
NO991920L (no) 1999-04-22
EP0938330A1 (de) 1999-09-01
TW534817B (en) 2003-06-01
NO323690B1 (no) 2007-06-25
IL129293A0 (en) 2000-02-17
DE59706334D1 (de) 2002-03-21
CA2219641A1 (en) 1998-04-30
ATE212856T1 (de) 2002-02-15
NZ335065A (en) 2000-06-23
AU5221798A (en) 1998-05-22
RU2193414C2 (ru) 2002-11-27
JP2001502702A (ja) 2001-02-27
WO1998018482A1 (de) 1998-05-07
ZA979693B (en) 1998-05-07
CA2219641C (en) 2008-12-23
DE19644994A1 (de) 1998-05-07
EP0938330B1 (de) 2002-02-06
BR9712456A (pt) 1999-10-19
PL333174A1 (en) 1999-11-22

Similar Documents

Publication Publication Date Title
Barbieri Hormone treatment of endometriosis: the estrogenthreshold hypothesis
RU2110274C1 (ru) Способ лечения состояния, зависящего от эстрогенов яичников
Gonzalez-Barcena et al. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
Giatras et al. Fertility after hysteroscopic resection of submucous myomas
Felberbaum et al. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix.
Aleem et al. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography
Smets et al. Expansive benign lesions: treatment by laser
Giorlandino et al. Ultrasound‐guided aspiration of ovarian endometriotic cysts
Dmowski et al. Recurrent endometriosis following hysterectomy and oophorectomy: the role of residual ovarian fragments
AU769482B2 (en) Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction
Maheux Treatment of uterine leiomyomata: past, present and future
Vollenhoven et al. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women
US20080255053A1 (en) Method for the therapeutic management of endometriosis
PL188998B1 (pl) Zastosowanie antagonistów LH-RH
Kuhlmann et al. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy
Brun et al. Results and factors influencing the outcome of 203 transcervical endometrial resections
MXPA99003613A (en) Use of lh-rh antagonists as diagnostic agent
Hull et al. Endometriosis: An enigmatic disease
Balasch et al. Endocrinology: Sequential gonadotrophin-releasing hormone agonist/low-dose oral contraceptive treatment for leiomyomata uteri
Aleandri et al. Report on a conference on developments in the treatment of benign gynecological disorders

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20091023